Hemex Health Awarded $3M NIH Grant to Bring Gazelle Hb Variant Test for Sickle Cell Disease to US Market
March 27, 2023 08:00 ET
|
Hemex Health
PORTLAND, Ore., March 27, 2023 (GLOBE NEWSWIRE) -- Hemex Health, a medical diagnostic device company focused on expanding healthcare access to underrepresented patient populations, announced it has...
Hemex Health and Mylab Discovery Solutions Launch Gazelle™ PathoCatch™ COVID-19 FIA Test
July 06, 2022 08:00 ET
|
Hemex Health
PORTLAND, Ore. and PUNE, India, July 06, 2022 (GLOBE NEWSWIRE) -- Mylab Discovery Solutions, India’s leading biotechnology company, and Portland, OR-based Hemex Health, a medical diagnostic device...
New Data to Be Presented at the 4th Global Congress on Sickle Cell Disease Will Spotlight High Accuracy from Hemex Health’s Gazelle™ Reader for Diagnosing Newborn Sickle Cell Disease, Beta Thalassemia and Monitoring Fetal Hemoglobin Levels
June 15, 2022 09:50 ET
|
Hemex Health
PORTLAND, Ore., June 15, 2022 (GLOBE NEWSWIRE) -- New clinical data from Hemex Health, a Portland, Oregon-based health-tech startup, will be spotlighted at the 4th Global Congress on Sickle Cell...
Hemex Health announces breakthrough measurement capability for clinicians monitoring sickle cell disease therapy
May 08, 2022 06:00 ET
|
Hemex Health
PORTLAND, Ore. and MUMBAI, India, May 08, 2022 (GLOBE NEWSWIRE) -- Hemex Health, a Portland, Oregon-based health-tech startup, announced a significant enhancement to their Gazelle™ Hb Variant test,...
New Research Reveals Gazelle Diagnostic Device Outperformed Rapid Diagnostic Test for P. Vivax Malaria, Detected Challenging Types of Malaria, and Provided Affordable Sickle Cell Disease Detection
November 16, 2020 16:10 ET
|
Hemex Health
PORTLAND, Ore., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Hemex Health, an innovator in point-of-care diagnostic technologies, announced today that researchers will present five scientific posters at the...
New Research Shows Gazelle Diagnostic Device Outperformed Rapid Diagnostic Test for P. Vivax Malaria, Detected Challenging Types of Malaria, and Provided Accurate Sickle Cell Disease Detection
November 15, 2020 14:00 ET
|
Hemex Health
PORTLAND, Ore., Nov. 15, 2020 (GLOBE NEWSWIRE) -- Hemex Health, an innovator in point-of-care diagnostic technologies, announced today that researchers will present five scientific posters at the...
NIH Awards Prize to Hemex Health’s Non-Invasive Sickle Cell, Malaria, Anemia Rapid Test (“SMART”) Diagnostic Technology
October 26, 2020 08:00 ET
|
Hemex Health
PORTLAND, Ore., Oct. 26, 2020 (GLOBE NEWSWIRE) -- Researchers from Hemex Health, Medtronic plc, Case Western Reserve University, and the University of Nebraska Medical Center’s International...
Gazelle® Diagnostic Platform, Designed for Low Resource Settings, Integrates Miniaturized Technologies with AI to Transform Disease Screening and Diagnosis
June 17, 2020 03:01 ET
|
Hemex Health
8-minute, Low-Cost Diagnostic Test for Sickle Cell Disease (SCD) Among First Approved Tests Includes a One-Minute Malaria Test with Solutions for Other Health Priorities to Follow PORTLAND, Ore. and...
PAI Life Science’s Biochemistry Expertise Links with Hemex Health’s Gazelle™ Miniaturized Rapid Diagnostic Platform to Develop Pandemic Test
April 15, 2020 11:00 ET
|
Hemex Health
SEATTLE and PORTLAND, Ore., April 15, 2020 (GLOBE NEWSWIRE) -- Researchers in Seattle and Portland have agreed to collaborate on an urgently needed rapid COVID-19 diagnostic test that can diagnose...